Drugs for Gastrointestinal Diseases Practice Questions

Q: Which of the following drugs is known to cause extrapyramidal adverse effects?

Metoclopramide. The correct answer is **Metoclopramide**.1. Why Metoclopramide is correct:Metoclopramide is a potent **D2 receptor antagonist** used as a prokinetic and antiemetic. Its mechanism involves blocking dopamine receptors in the Chemoreceptor Trigger Zone (CTZ). Crucially, metoclopramide is a lipophilic molecule that **crosses the blood-brain barrier (BBB)**. By blocking D2 receptors in the nigrostriatal pathway of the basal ganglia, it disrupts the dopaminergic-cholinergic balance, leading to **Extrapyramidal Side Effects (EPS)** such as acute dystonia, akathisia, and parkinsonism (especially in children and young adults) [1].2. Why the other options are incorrect:* **Domperidone:** While also a D2 receptor antagonist, it **does not cross the BBB** effectively (it acts on the CTZ which lies outside the BBB). Therefore, it is virtually free of EPS. Its primary side effects are related to hyperprolactinemia (galactorrhea, gynecomastia) because the pituitary gland is also outside the BBB.* **Cisapride:** This is a **5-HT4 receptor agonist** that increases ACh release in the myenteric plexus. It does not have significant D2 blocking activity and thus does not cause EPS. (Note: It was largely withdrawn due to QT interval prolongation and *Torsades de Pointes*) [2].High-Yield Clinical Pearls for NEET-PG:* **Drug of Choice:** Metoclopramide is the drug of choice for **Diabetic Gastroparesis**.* **Management of EPS:** If metoclopramide induces acute dystonia, the treatment of choice is an intravenous anticholinergic like **Promethazine** or **Diphenhydramine**.* **Contraindication:** Avoid metoclopramide in patients with **Parkinson’s disease** (exacerbates symptoms) and **Mechanical Bowel Obstruction** (risk of perforation due to prokinetic action).

Q: Atropine is added with diphenoxylate to achieve which of the following?

Decrease abuse potential. **Explanation:** **Diphenoxylate** is a synthetic opioid derivative used as an anti-diarrheal agent. It works by activating $\mu$-opioid receptors in the gastrointestinal tract, thereby decreasing intestinal motility. **Why Option C is correct:** Although diphenoxylate is used for its peripheral effects on the gut, it is structurally related to pethidine. At high doses, it can cross the blood-brain barrier and produce opioid-like euphoria and physical dependence. To prevent such misuse, a sub-therapeutic (non-pharmacological) dose of **Atropine** is added. If an individual attempts to take a large dose of the combination to achieve a "high," they will experience the unpleasant symptoms of atropine toxicity (anticholinergic effects) such as dry mouth, blurred vision, palpitations, and urinary retention [1], [2]. This serves as a **deterrent**, effectively decreasing the drug's abuse potential. **Why other options are incorrect:** * **A & D:** Atropine does not synergize with diphenoxylate’s anti-diarrheal efficacy nor does it improve its pharmacokinetic profile (absorption). * **B:** Atropine actually *adds* its own side effects to the profile rather than decreasing those of diphenoxylate [2]. **High-Yield NEET-PG Pearls:** * **Lomotil:** The brand name for the combination of Diphenoxylate + Atropine. * **Loperamide:** Another opioid anti-diarrheal; it is preferred over diphenoxylate because it has poor CNS penetration and a lower abuse potential, so it does not require atropine addition. * **Contraindication:** Avoid these agents in infectious diarrhea (e.g., *Salmonella*, *Shigella*) as they may delay the clearance of organisms and lead to toxic megacolon [3].

Q: Which of the following drugs crosses the blood-brain barrier?

Diphenoxylate. ### Explanation **Correct Answer: D. Diphenoxylate** **Mechanism and Concept:** Diphenoxylate is a synthetic opioid derivative used as an anti-motility agent for diarrhea. Unlike many other peripheral opioids, diphenoxylate is structurally related to pethidine and is lipid-soluble enough to **cross the blood-brain barrier (BBB)**. At high therapeutic doses, it can produce central opioid effects (euphoria and sedation). To prevent drug abuse, it is commercially formulated in combination with a sub-therapeutic dose of **Atropine** (Lomotil), which causes unpleasant anticholinergic side effects if taken in excess. **Analysis of Incorrect Options:** * **A. Loperamide:** Although it is an opioid derivative, it does **not** cross the BBB in significant amounts under normal conditions. It is a substrate for the **P-glycoprotein (P-gp) efflux pump**, which actively pumps the drug out of the brain. Thus, it lacks central effects and has no abuse potential. * **B. Kaolin:** This is a naturally occurring hydrated aluminum silicate. It acts as an **adsorbent** that binds toxins and water in the GI tract. It is not absorbed systemically and therefore cannot cross the BBB. * **C. Methylcellulose:** This is a **bulk-forming laxative** (hydrophilic colloid). It absorbs water to increase stool bulk and promote peristalsis. It is pharmacologically inert and remains within the lumen of the gut. **NEET-PG High-Yield Pearls:** * **Loperamide** is the drug of choice for non-infectious traveler’s diarrhea because it lacks CNS side effects. * **Eluxadoline** is a newer mu-opioid receptor agonist used for Irritable Bowel Syndrome with Diarrhea (IBS-D). * **Racecadotril** is an enkephalinase inhibitor used in pediatric diarrhea; it increases endogenous enkephalins to reduce intestinal secretion without affecting motility.

Q: Which of the following medications is used to directly relax the lower esophageal sphincter?

Isosorbide dinitrate. **Explanation:** **Correct Option: D. Isosorbide dinitrate** Isosorbide dinitrate is a **nitrate** that acts as a nitric oxide (NO) donor. In the gastrointestinal tract, NO is the primary inhibitory neurotransmitter responsible for the relaxation of smooth muscles. It stimulates guanylyl cyclase, increasing cGMP levels, which leads to the dephosphorylation of myosin light chains and subsequent relaxation of the **lower esophageal sphincter (LES)**. Clinically, nitrates (along with Calcium Channel Blockers like Nifedipine) are used as pharmacological interventions to reduce LES pressure in patients with **Achalasia Cardia** who are not candidates for surgery or pneumatic dilation. **Incorrect Options:** * **A. Diphenoxylate:** An opioid derivative used as an **anti-diarrheal** agent. It acts on μ-opioid receptors in the gut to decrease intestinal motility; it does not relax the LES. * **B. Famotidine:** An **H2-receptor antagonist** that reduces gastric acid secretion. It is used in GERD and peptic ulcer disease but has no direct effect on LES tone. * **C. Granisetron:** A selective **5-HT3 receptor antagonist** used primarily as an anti-emetic (especially for chemotherapy-induced nausea and vomiting). It acts on the chemoreceptor trigger zone (CTZ) and vagal afferents. **High-Yield Clinical Pearls for NEET-PG:** * **Achalasia Cardia Treatment:** Pharmacotherapy is the least effective long-term treatment. Gold standard treatments include **Heller’s Myotomy** or **POEM** (Peroral Endoscopic Myotomy). * **Botulinum Toxin:** Can be injected endoscopically into the LES to inhibit acetylcholine release, thereby inducing relaxation in Achalasia. * **Drug-Induced LES Relaxation:** Other drugs that decrease LES pressure (and may worsen GERD) include Theophylline, Anticholinergics, and Progesterone.

Q: Which antiemetic drug selectively blocks levodopa-induced vomiting without blocking its anti-Parkinsonian action?

Domperidone. ### Explanation **Correct Option: C. Domperidone** The Chemoreceptor Trigger Zone (CTZ), which triggers vomiting, is located in the *area postrema* of the medulla. While the CTZ is anatomically in the brain, it lies **outside the Blood-Brain Barrier (BBB)**. Levodopa, used in Parkinson’s disease, is converted to dopamine, which stimulates D2 receptors in the CTZ, causing nausea and vomiting [1]. **Domperidone** is a peripheral D2 receptor antagonist [2]. Because it **does not cross the BBB**, it effectively blocks D2 receptors in the CTZ (relieving vomiting) without interfering with the D2 receptors in the basal ganglia (preserving the anti-Parkinsonian effect) [1]. **Why other options are incorrect:** * **A. Metoclopramide:** This is a central D2 antagonist that **crosses the BBB**. It would block dopamine receptors in the basal ganglia, worsening Parkinsonian symptoms or causing Extrapyramidal Side Effects (EPS) [1]. * **B. Cisapride:** This is a prokinetic agent that acts primarily as a 5-HT4 agonist. It does not have significant D2-blocking activity and is not the drug of choice for levodopa-induced emesis. * **D. Ondansetron:** This is a 5-HT3 receptor antagonist [2]. While it is a potent antiemetic (especially for chemo-induced vomiting), it is not the specific pharmacological "antidote" for dopamine-mediated emesis in Parkinson’s patients. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Domperidone is the preferred antiemetic for patients on Levodopa or Bromocriptine. * **Side Effects:** Though it lacks EPS, Domperidone can still cause **hyperprolactinemia** (galactorrhea/gynecomastia) because the pituitary gland also lies outside the BBB. * **Cardiac Warning:** Intravenous domperidone is associated with **QT interval prolongation** and cardiac arrhythmias.

Q: Crofelemer is a:

CFTR blocker. **Explanation:** **Crofelemer** is a first-in-class antidiarrheal agent derived from the botanical latex of the *Croton lechleri* tree. 1. **Why the correct answer is right:** Crofelemer acts as a potent inhibitor of both the **Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)** chloride channel and the calcium-activated chloride channels (CaCC) on the luminal membrane of enterocytes. By blocking these channels, it reduces the secretion of chloride ions and associated water into the intestinal lumen. It is specifically FDA-approved for the symptomatic relief of **non-infectious diarrhea in patients with HIV/AIDS** on anti-retroviral therapy (ART). 2. **Why the incorrect options are wrong:** * **Chloride channel activator:** Drugs like **Lubiprostone** activate ClC-2 channels to increase fluid secretion; they are used for constipation, not diarrhea. * **Somatostatin antagonist:** There is no major clinical drug in this category for GI diseases. Conversely, Somatostatin *analogs* (e.g., **Octreotide**) are used to treat secretory diarrhea. * **Guanylate cyclase-C (GC-C) agonist:** Drugs like **Linaclotide** and **Plecanatide** stimulate GC-C to increase cGMP, leading to chloride/fluid secretion. They are used to treat Chronic Idiopathic Constipation (CIC) and IBS-C. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Luminal, non-systemic inhibition of CFTR and CaCC. * **Indication:** HIV-associated diarrhea (where ART causes secretory imbalances). * **Key Distinction:** Unlike loperamide, Crofelemer does not affect GI motility or opioid receptors, making it safer regarding constipation side effects. * **Source:** Botanical origin (*Dragon’s Blood* sap).

Q: Which of the following inhibit gastric secretion by blocking H2 receptors?

Ranitidine. Explanation: The secretion of gastric acid by parietal cells is regulated by three main secretagogues: **Histamine** (acting on H2 receptors), **Gastrin**, and **Acetylcholine** (M3 receptors) [3]. **1. Why Ranitidine is Correct:** **Ranitidine** is a competitive antagonist of the **H2 receptors** located on the basolateral membrane of parietal cells [2], [4]. By blocking these receptors, it inhibits the histamine-induced activation of adenylyl cyclase, leading to decreased intracellular cAMP levels and a significant reduction in both basal and stimulated gastric acid secretion [3]. **2. Why Other Options are Incorrect:** * **Omeprazole:** This is a **Proton Pump Inhibitor (PPI)**. It irreversibly inhibits the $H^+/K^+$ ATPase enzyme (the final common pathway of acid secretion) rather than blocking H2 receptors [1]. * **Sucralfate:** This is a **cytoprotective agent**. It polymerizes in an acidic environment (pH < 4) to form a sticky paste that binds to the ulcer base, acting as a physical barrier against acid and pepsin. It does not inhibit acid secretion. * **Misoprostol:** This is a **Prostaglandin E1 (PGE1) analogue**. It inhibits acid secretion by binding to **EP3 receptors** and also increases mucosal bicarbonate and mucus production [1]. **High-Yield Clinical Pearls for NEET-PG:** * **H2 Blockers:** Cimetidine (the prototype) is notorious for causing **gynecomastia** and being a potent **Cytochrome P450 inhibitor**. Ranitidine is preferred as it lacks these anti-androgenic effects. * **Drug of Choice:** While H2 blockers are effective, **PPIs** are the drugs of choice for GERD, Peptic Ulcer Disease, and Zollinger-Ellison Syndrome due to their superior efficacy. * **Tolerance:** H2 blockers can show "tachyphylaxis" (rapidly diminishing response) within 3-5 days of use, a phenomenon not seen with PPIs.

Q: A person needs to travel to Shimla the next morning. What medication should be administered to prevent motion sickness?

Scopolamine patch applied the night before. ### Explanation **Correct Option: A. Scopolamine patch applied the night before** Motion sickness is caused by a mismatch between vestibular, visual, and somatosensory inputs. The vestibular system relies on **muscarinic (M1)** and **histaminergic (H1)** receptors to transmit signals to the vomiting center. **Scopolamine (Hyoscine)**, a potent anticholinergic, is the drug of choice for prophylaxis. The transdermal patch is preferred for long journeys because it provides a sustained release of the drug. It must be applied to the retroauricular (behind the ear) area **at least 4–6 hours (or the night before)** the journey to ensure therapeutic plasma concentrations are reached before the vestibular stimulus begins. **Analysis of Incorrect Options:** * **B & D (Ranitidine/Omeprazole):** These are H2-receptor antagonists and Proton Pump Inhibitors (PPIs), respectively. They reduce gastric acid secretion and are used for GERD or peptic ulcers, but they have no effect on the vestibular system or motion sickness. * **C (Dimenhydrinate):** While H1-antihistamines like Dimenhydrinate are effective for motion sickness, they have a short duration of action. Taking it only one hour prior may be effective for short trips, but for a long journey (like traveling to a hill station), the Scopolamine patch is superior due to its 72-hour efficacy and prophylactic steady-state levels. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Scopolamine blocks M1 receptors in the vestibular apparatus and the nucleus tractus solitarius. * **Timing is Key:** Antiemetics for motion sickness are **prophylactic**; they are ineffective once vomiting has started. * **Side Effects:** Common anticholinergic effects include dry mouth, blurred vision (cycloplegia), and sedation. * **Alternative:** For acute/short-term prophylaxis, **Promethazine** or **Cyclizine** (H1 blockers) can be used.

Question 1

Which of the following drugs is known to cause extrapyramidal adverse effects?

Accepted Answer

Metoclopramide

Answer

Domperidone

Answer

Cisapride

Answer

All of the above

Question 2

Atropine is added with diphenoxylate to achieve which of the following?

Accepted Answer

Decrease abuse potential

Answer

Increase effect

Answer

Decrease side effects

Answer

Enhance absorption

Question 3

Which of the following drugs crosses the blood-brain barrier?

Accepted Answer

Diphenoxylate

Answer

Loperamide

Answer

Kaolin

Answer

Methylcellulose

Question 4

Which of the following medications is used to directly relax the lower esophageal sphincter?

Accepted Answer

Isosorbide dinitrate

Answer

Diphenoxylate

Answer

Famotidine

Answer

Granisetron

Question 5

Which antiemetic drug selectively blocks levodopa-induced vomiting without blocking its anti-Parkinsonian action?

Accepted Answer

Domperidone

Answer

Metoclopramide

Answer

Cisapride

Answer

Ondansetron

Question 6

Which proton pump inhibitor can be administered intravenously?

Accepted Answer

Pantoprazole

Answer

Omeprazole

Answer

Rabeprazole

Answer

Fomepizole

Question 7

In antacid preparations, why is aluminum hydroxide added with a magnesium salt?

Accepted Answer

To counteract the constipating effect of aluminum hydroxide.

Answer

Magnesium causes constipation.

Answer

To counteract the diarrheal action of aluminum.

Answer

Aluminum salt causes diarrhea.

Question 8

Crofelemer is a:

Accepted Answer

CFTR blocker

Answer

Chloride channel activator

Answer

Somatostatin antagonist

Answer

Guanylate cyclase agonist

Question 9

Which of the following inhibit gastric secretion by blocking H2 receptors?

Accepted Answer

Ranitidine

Answer

Omeprazole

Answer

Sucralfate

Answer

Misoprostol

Question 10

A person needs to travel to Shimla the next morning. What medication should be administered to prevent motion sickness?

Accepted Answer

Scopolamine patch applied the night before

Answer

Ranitidine administered the night before and again before the trip

Answer

Dimenhydrinate taken one hour prior to the journey

Answer

Omeprazole taken thirty minutes before the trip

Drugs for Gastrointestinal Diseases — MCQs

Drugs for Gastrointestinal Diseases — MCQs

On this page

Practice by Chapter

Want unlimited practice?